The 2007 Recommendations of the International Commission on Radiological Protection (ICRP, 2007) introduced changes that affect the calculation of effective dose and implied a revision of the dose coefficients for internal exposure, published previously in the Publication 30 series and Publication 68. In addition, new data are available that support an update of the radionuclide-specific information given in Publications 54 and 78 for the design of monitoring programs and retrospective assessment of occupational internal doses. Provision of new biokinetic models, dose coefficients, monitoring methods, and bioassay data was performed by Committee 2, Task Group 21 on Internal Dosimetry, and Task Group 4 on Dose Calculations.
A new series, the Occupational Intakes of Radionuclides (OIR) series, is going to replace the Publication 30 series and Publications 54, 68, and 78. Part 1 of the OIR series has been issued in 2015, and describes the assessment of internal occupational exposure to radionuclides, biokinetic and dosimetric models, methods of individual and workplace monitoring, and general aspects of retrospective dose assessment.
The following publications in the OIR series (Parts 2–5) will provide data on individual elements and their radioisotopes, including
information on chemical forms encountered in the workplace
a list of principal radioisotopes and their physical half-lives and decay modes
the parameter values of the reference biokinetic model
Reviews of data on inhalation, ingestion, and systemic biokinetics are also provided for most of the elements. Dosimetric data provided in the printed publications of the OIR series include
tables of committed effective dose per intake (Sv per Bq intake) for inhalation and ingestion,
tables of committed effective dose per content (Sv per Bq measurement) for inhalation,
These data are provided for all absorption types and for the most common isotope(s) of each element. The electronic annex that accompanies the OIR series of reports contains a comprehensive set of committed effective and equivalent dose coefficients, committed effective dose per content functions, and reference bioassay functions. Data are provided for inhalation, ingestion, and direct input to blood.
The second publication in the series (ICRP Publication 134) the above data are presented for the following elements: hydrogen (H), carbon (C), phosphorus (P),sulphur (S), calcium (Ca), iron (Fe), cobalt (Co), zinc (Zn), strontium (Sr), yttrium(Y), zirconium (Zr), niobium (Nb), molybdenum (Mo), and technetium (Tc) (ICRP, 2016). The third publication in the series (ICRP Publication 137) provides the above data for the following elements: ruthenium (Ru), antimony (Sb), tellurium (Te), iodine (I), caesium (Cs), barium (Ba), iridium (Ir), lead (Pb), bismuth (Bi), polonium (Po), radon (Rn), radium (Ra), thorium (Th), and uranium (U) (ICRP, 2017). The fourth publication in the series (ICRP Publication 141) provides the above data for the following elements: lanthanum (La), cerium (Ce), praseodymium (Pr), neodymium (Nd), promethium (Pm), samarium (Sm), europium (Eu), gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), ytterbium (Yb), lutetium (Lu), actinium (Ac), protactinium (Pa), neptunium (Np), plutonium (Pu), americium (Am), curium (Cm), berkelium (Bk), californium (Cf), einsteinium (Es), and fermium (Fm).
IDEA System has implemented all information
provided in the OIR series by now and thus created a new version IDEAplus with improved
precision and accuracy.